Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Gemmill MC, Thomson S, Mossialos E.

Int J Equity Health. 2008 May 2;7:12. doi: 10.1186/1475-9276-7-12.

2.

Managing hypertension in patients with renal disease and diabetes.

Grad R, Hanley S.

CMAJ. 2000 May 30;162(11):1555-6. No abstract available.

3.

Managing hypertension in patients with renal disease and diabetes.

Bell A.

CMAJ. 2000 May 30;162(11):1554-5; author reply 1556. No abstract available.

4.

Access to the morning-after pill in BC.

Gutowski WD.

CMAJ. 2000 May 30;162(11):1554. No abstract available.

5.

Access to the morning-after pill in BC.

Osmond B.

CMAJ. 2000 May 30;162(11):1554. No abstract available.

6.

Patient compliance with drug therapy for diabetic nephropathy.

Hughes D, Manns B.

CMAJ. 2000 May 30;162(11):1553-4. No abstract available.

7.

To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.

Clark WF, Churchill DN, Forwell L, Macdonald G, Foster S.

CMAJ. 2000 Jan 25;162(2):195-8. Erratum in: CMAJ 2000 Apr 4;162(7):973.

8.

Practitioners and health policy. Case of the Ontario Drug Benefit Plan.

Shortt SE.

Can Fam Physician. 1995 Dec;41:2053-60, 2070-6. English, French. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk